Abstract
A randomized two-stage adaptive Bayesian design is proposed and studied for allocation and comparison in a phase III clinical trial with survival time as treatment response. Several exact and limiting properties of the design and the follow-up inference are studied, both numerically and theoretically, and are compared with a single-stage randomized procedure. The applicability of the proposed methodology is illustrated by using some real data.
Similar content being viewed by others
References
Abdushukorov AA (1984) On some estimates of the distribution function under random censorship. In: Conference of young scientists. Math Inst Acad Sci. Urbek. SSR. Taschkent. VINTI No 8756 (in Russian)
Anderson PK, Borgan Ø, Gill RD, Keiding N (1993) Statistical models based on counting processes. Springer, New York
Atkinson AC (1982) Optimal biased coin design for sequential clinical trials with prognostic factors. Biometrika 69: 61–67
Atkinson AC, Biswas A (2005) Bayesian adaptive biased coin design for sequential clinical trials. Biometrics 61: 118–125
Atkinson AC, Donev AN (1996) Optimum experimental designs. Oxford University Press, Oxford
Ball FG, Smith AFM, Verdinelli I (1993) Biased coin designs with a Bayesian bias. J Stat Plan Inference 34: 403–421
Bandyopadhyay U, Biswas A (2001) Adaptive designs for normal responses with prognostic factors. Biometrika 88: 409–419
Bandyopadhyay U, Biswas A, Bhattacharya R (2007) Covariate adjusted two stage allocation design for binary responses in randomized clinical trials. Stat Med 26: 4386–4399
Bartlett RH, Roloff DW, Cornell RG, Andrews AF, Dillon PW, Zwischenberger JB (1985) Extracorporeal circulation in neonatal respiratory failure: a prospective randomized trial. Pediatrics 76: 479–487
Bauer M, Bauer P, Buddle M (1994) A simulation program for adaptive two stage designs. Comput Stat Data Anal 26: 351–371
Bauer P, Brannath W, Posch M (2001) Flexible two-stage designs: an overview. Methods Inf Med 40: 117–121
Biswas A, Dewanji A (2004) A randomized longitudinal play-the-winner design for repeated binary data. Aust N Z J Stat 46: 675–684
Braekers R, Veraverbeke N (2001) The partial Kojiol-Green model with covariates. J Stat Plan Inference 92: 55–71
Chen CH (1984) A correlation goodness-of-fit test for randomly censored data. Biometrika 71: 315–322
Chen YY, Hollander M, Langberg NA (1982) Small-sample results for the Kaplan–Meier estimator. J Am Stat Assoc 77: 141–144
Cheng CH, Lin GD (1987) Maximum likelihood estimation of a survival function under the Koziol–Green proportional hazards model. Stat Probab Lett 5: 75–80
Cheung YK, Thall PF (2002) Monitoring the rates of composite events with censored data in phase I clinical trials. Biometrics 58: 89–97
Coad DS (1992) Some results on estimation for two stage clinical trials. Sequential Anal 11: 299–311
Coad DS (1994) Sequential estimation for two-stage and three-stage clinical trials. J Stat Plan Inference 43: 343–351
Cox DR (1959) The analysis of exponentially distributed life-times with two types of failure. J R Stat Soc B 21: 411–421
Csorgo S (1989) Testing the proportional hazards model of random censorship. In: Mandl P, Huskova M (eds) Proceedings of the fourth prague symposium on asymptotic statistics. Charles University Press, Prague, pp 41–53
Csorgo S, Horvath L (1981) On the Koziol–Green model for random censorship. Biometrika 68: 391–401
Dauxois J-Y, Kirmani SNUA (2003) On testing the proportionality of two cumulative incidence functions in a competing risks setup. Nonparametr Stat 16: 479–491
de Una-Alvarez J, Gonzalez-Manteiga W (1998) Distributional convergence under proportional censorship when covariates are present. Stat Prob Lett 39: 305–315
de Una-Alvarez J, Gonzalez-Manteiga W (1999) Strong consistency under proportional censorship when covariates are present. Stat Prob Lett 42: 283–292
Durham S, Flournoy N, Li W (1998) A sequential design for maximising the probability of a favourable response. Can J Stat 26: 479–495
Ebrahimi N (1985) Nonparametric estimation of survival functions for incomplete observations when the life time distribution is proportionally related to the censoring time distribution. Commun Stat Theory Methods 14: 2887–2898
Ebrahimi N, Habibullah M (1992) Testing to determine the underlying distribution using incomplete observations when the life time distribution is proportionally related to the censoring time distribution. J Stat Comput Simul 40: 109–118
Feigl P, Zelen M (1965) Estimation of exponential survival probabilities with concomitant information. Biometrics 21: 826–838
Flehinger B, Louis T. (1971) A sequential treatment allocation in clinical trials. Biometrika 58: 419–426
Freireich EJ et al (1963) The effect of 6-Mercaptopurine on the duration of steroid induced remission in ‘Acute Leukemia’. Blood 21: 699–716
Gather U, Pawlitschko J (1999) Estimating the survival function under a generalized Koziol–Green model with partially informative censoring. Metrika 48: 189–207
Ghorai JK (1991) Estimation of a smooth quantile function under the proportional hazards model. Ann Inst Stat Math 43: 747–760
Gijbels I, Veraverbeke N (1989) Quantile estimation in the proportion hazards model of random censorship. Commun Stat Theory Methods 18: 1645–1663
Gross AJ, Clark VA (1975) Survival distributions: reliability applications in the biomedical sciences. Wiley, New York
Hajek J, Sidak Z (1967) Theory of rank tests. Academic Press, New York
Hallstrom A, Brooks MM, Peckovia M (1996) Logrank, play the winner, power and ethics. Stat Med 15: 2135–2142
Henze N (1993) A quick omnibus test for the proportional hazards model of random censorship. Statistics 24: 253–263
Herbst T (1992) Test of fit with the Koziol–Green model for random censorship. Stat Decis 10: 163–171
Hollander M, Proschan F (1979) Testing to determine the underlying distribution using randomly censored data. Biometrics 35: 393–401
Hsieh FY (1992) Comparing sample size formulas for trials with unbalanced allocation using the logrank test. Stat Med 11: 1091–1098
Iglewicz B (1983) Alternative designs: sequential, multi-stage, decision theory and adaptive designs. In: Buyse ME, Staquet J, Sylvester RJ (eds) Cancer clinical trials: methods and practice. Oxford University Press, Oxford, pp 312–324
Ivanova A (2003) A play-the-winner-type urn design with reduced variability. Metrika 58: 1–13
Koziol JA, Green SB (1976) A Cramer-von Mises statistic for randomly censored data. Biometrika 63: 465–474
Lawless JF (1976) Confidence interval estimation in the inverse power law model. Appl Stat 25: 128–138
Lawrence J (2002) Strategies for changing the test statistic during a clinical trial. J Biopharm Stat 12: 193–205
Liu Q, Chi GY (2001) On sample size and inference for two-stage adaptive designs. Biometrics 57: 172–177
Liu Q, Proschan MA, Pledger GW (2002) A unified theory of two-stage adaptive designs. J Am Stat Assoc 97: 1034–1041
Matthews JNS (2000) An introduction to randomized controlled clinical trials. Edward Arnold, London
Muller H, Schafer H (2001) Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches. Biometrics 57: 886–891
Pawlitschko J (1999) A comparison of survival function estimators in the Koziol–Green model. Statistics 32: 277–291
Posch M, Bauer P (1999) Adaptive two stage designs and the conditional error function. Biometrical J 41: 689–696
Prentice RL (1973) Exponential survival with censoring and explanatory variables. Biometrika 61: 539–544
Proschan MA, Hunsberger SA (1995) Designed extension of studies based on conditional power. Biometrics 51: 1315–1324
Proschan MA, Liu Q, Hunsberger S (2003) Practical midcourse sample size modification in clinical trials. Control Clin Trials 24: 4–15
Rosenberger WF (2003) Adaptive survival trials. In: Chow S-C (eds) Encyclopedia of biopharmaceutical statistics, 2nd edn. Dekkar, New York, pp 16–17
Rosenberger WF, Lachin JL (2002) Randomization in clinical trials: theory and practice. Wiley, New York
Rosenberger WF, Seshaiyer P (1997) Adaptive survival trials. J Biopharm Stat 7: 617–624
Rout CC, Rocke DA, Levin J, Gouws E, Reddy D (1993) A reevaluation of the role of crystalloid preload in the prevention of hypotension associated with spinal anesthesia for elective cesarean section. Anesthesiology 79: 768–776
Sposto R, Krailo MD (1987) Use of unequal allocation in survival trials. Stat Med 7: 629–637
Stute W (1992) Strong consistency under the Koziol–Green model. Stat Probab Lett 14: 313–320
Subramanian S (2000) Efficient estimation of regression coefficients and baseline hazard under proportionality of conditional hazard. J Stat Plan Infer 84: 81–94
Tamura RN, Faries DE, Andersen JS, Heiligenstein JH (1994) A case study of an adaptive clinical trials in the treatment of out-patients with depressive disorder. J Am Stat Assoc 89: 768–776
The Trials of Hypertension Prevention Collaborative Research Group (1992) The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. J Am Med Assoc 267:1213–1220
Veraverbeke N, Cadarso-Suarez C (2000) Estimation of the conditional distribution in a conditional Koziol–Green model. Test 9: 97–122
Ware JH (1989) Investigating therapies of potentially great benefit: ECMO. Stat Sci 4: 298–340
Wei LJ, Durham S (1978) The randomized play-the-winner rule in medical trials. J Am Stat Assoc 73: 838–843
Yao Q, Wei LJ (1996) Play the winner for phase II and III clinical trials. Stat Med 15: 2413–2423
Zeymer U, Suryapranata H, Monassier JP, Opolski G, Davies J, Rasmanis G, Linssen G, Tebbe U, Schroder R, Tiemann R, Machnig T, Neuhaus K-L, forthe ESCAMI Investigators (2001a) The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infraction. J Am Coll Cardiol 38: 1644–1651
Zeymer U, Suryapranata H et al (2001b) Evaluation of the safety and cardioprotective effects of eniporide, a specific Sodium/Hydrogen exchange inhibitor, given as adjunctive therapy to reperfusion in patients with acute myocardial infraction. Heart Drug 1: 71–76
Zelen M (1959) Factorial experiments in life testing. Technometrics 1: 269–288
Zelen M (1969) Play-the-winner rule and controlled clinical trial. J Am Stat Assoc 64: 131–146
Zhang L, Rosenberger WF (2007) Response-adaptive randomization for survival trials: the parametric approach. J R Stat Soc Ser C 34: 562–569
Zheng G, Gastwirth JL (2001) On the Fisher information in randomly censored data. Stat Probab Lett 52: 421–426
Zheng G, Gastwirth JL (2003) Fisher information in ordered randomly censored data with applications to characterization problems. Stat Sin 13: 507–517
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bandyopadhyay, U., Biswas, A. & Bhattacharya, R. A Bayesian adaptive design for two-stage clinical trials with survival data. Lifetime Data Anal 15, 468–492 (2009). https://doi.org/10.1007/s10985-009-9134-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10985-009-9134-4